Xiidra Patient Assistance Program
Xiidra (lifitegrast) is an eye drop prescribed for adults with dry eye disease. Along with environmental modifications and artificial tears, it works by blocking certain proteins that cause inflammation on the eye surface and belongs to a class of medications called lymphocyte function-associated antigen-1 antagonists.
Dry eye disease requires consistent treatment to manage symptoms and prevent worsening, yet inadequate prescription coverage for eye drops often creates barriers. Fortunately, manufacturers offer Patient Assistance Programs (PAPs) designed to address challenges you might have getting your medication.
How Prescription Details Affect Xiidra Assistance Eligibility

About the Xiidra Patient Assistance Program
These programs exist for adults dealing with dry eye symptoms who find prescription treatment out of reach. The program evaluates applications based on income and insurance status, then provides Xiidra consistently to those who rely on the medication.
Enrollment starts with documentation from your eye care provider confirming your prescription along with proof of household income.
Patient Help Network takes responsibility for the paperwork and communication required to complete your application. We obtain necessary verification from your ophthalmologist or optometrist, assemble your financial information according to program specifications, and submit everything to the manufacturer. If you’re approved, Xiidra gets delivered to your house.
How Xiidra Works
Chronic dry eye creates ongoing discomfort that interferes with reading, screen time, and driving. The problem stems from inflammation damaging both your tear-producing glands and eye surface, creating a self-perpetuating cycle. Xiidra targets lymphocyte function-associated antigen-1, a specific protein driving inflammatory processes on the eye surface.
By reducing this inflammation, Xiidra may help improve the signs and symptoms of dry eye disease over time.
Treatment involves instilling one drop in each eye twice daily, spaced roughly twelve hours apart. Xiidra builds therapeutic effects over days and weeks rather than providing immediate relief. Many people notice improvement around two weeks into treatment, with full benefits often taking six to twelve weeks. Xiidra may not work for everyone.
Side Effects and Safety Information
Eye drops reducing inflammation can cause reactions at the application site. Burning, stinging, or grittiness right after application happens frequently and usually fades within minutes. Vision may blur temporarily. Many experience an unusual taste when drops drain through tear ducts into the throat.
Most reactions diminish as your eyes adjust to regular use.
Some develop redness, increased tearing, or eyelid swelling. Clinical trials showed headaches and sinus infections occurring more often with Xiidra than placebo. Allergic reactions are possible though uncommon.
Contact your provider if discomfort lasts longer than several minutes, if vision changes persist, or if you develop pain, light sensitivity, or discharge. Remove contact lenses before applying Xiidra and wait fifteen minutes before reinserting them.
Step 1 – Submit Application
Provide basic prescription and household information to begin the application process.
Step 2 – Application Review
Information is reviewed and submitted to appropriate Patient Assistance Programs.
Step 3 – Program Decision
Final eligibility decisions are made by each program. Additional steps or renewals may be required.
PHN will contact you within 24 hours to discuss your situation and help identify appropriate next steps for the application process.
How it applies / Eligibility
Patient assistance programs evaluate applications based on specific eligibility criteria. To be eligible, a person must meet these requirements:
- Single patients earning less than $40,000 per year
- Couples making under $60,000 combined yearly
- Households with three or more people bringing in below $100,000 annually
- Active Xiidra prescription from your healthcare provider
- Proof of U.S. citizenship or legal residency
- Limited or inadequate prescription drug coverage for Xiidra
Income represents only one factor among several that manufacturers consider.
Each program weighs different criteria when deciding who qualifies, and every application gets evaluated individually. Some programs maintain waiting lists depending on available capacity, so applying early improves your chances of timely enrollment.
Frequently asked questions (FAQ`s)
Rejections explain why approval didn’t happen. Income exceeding limits, existing insurance deemed sufficient, or incomplete materials account for most denials. You can submit a new application if your situation changes or if you provide missing documentation.
Continued participation requires proving annually you still meet standards. Provide updated income information and have your eye doctor confirm your prescription remains current. Missing renewal deadlines ends enrollment and requires reapplying.
Applications require a current Xiidra prescription from your licensed provider, household annual income records, citizenship or residency documentation, and prescription insurance details.
Patient Help Network manages enrollment from start to finish. We verify baseline requirements, collect necessary documentation, communicate with your eye care team for approvals, and file complete applications.
While a generic lifitegrast product has received FDA approval, patents prevent generic manufacturing, meaning only brand-name Xiidra is available.
Decision timing varies with application volume and processing capacity. Patient Help Network checks application status and provides updates as reviews progress.
Manufacturers can modify program parameters, including income thresholds and coverage definitions. Patient Help Network tracks changes and notifies applicants when modifications affect eligibility.